BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Swedish Orphan Biovitrum 

SE-112

  76 Stockholm    Sweden
Phone: 46-8-697-20-00 Fax: n/a


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Swedish Orphan Biovitrum Awarded Company Of The Year At The European Mediscience Awards 2014 7/1/2014 9:27:19 AM
Swedish Orphan Biovitrum Establishes North American Office In Massachusetts 6/5/2014 9:33:21 AM
Auxilium Pharmaceuticals (AUXL) And Swedish Orphan Biovitrum Announce Encore Presentation Of XIAFLEX/Xiapex Data At European Association Of Urology Congress 4/14/2014 6:14:09 AM
Swedish Orphan Biovitrum Release: Kiobrina Pivotal Phase 3 Study Did Not Meet Primary Endpoint 3/26/2014 9:29:05 AM
Biogen Idec, Inc. (Massachusetts) (BIIB) And Swedish Orphan Biovitrum Release: New Phase 3 Data Confirm Long-Lasting Characteristics Of ALPROLIX™ And ELOCTATE™ Across Multiple Hemophilia Populations 12/9/2013 9:51:53 AM
Swedish Orphan Biovitrum's Partner Biogen Idec, Inc. (Massachusetts) (BIIB) To Present Phase 3 Data On Prolonged Half-Life Of Hemophilia Candidates In Young Children At Annual American Society of Hematology Meeting 12/3/2013 9:22:09 AM
New Number Of Shares And Votes In Swedish Orphan Biovitrum 12/2/2013 9:40:45 AM
Swedish Orphan Biovitrum Receives Positive CHMP Opinion for Kineret® for Treatment of Rare Disease CAPS 9/23/2013 9:20:38 AM
Swedish Orphan Biovitrum Acquires Full Rights for Kineret® and Additional Clinical Data for Kepivance®From Amgen (AMGN) 9/9/2013 9:26:19 AM
Swedish Orphan Biovitrum Appoints Dennis Schmidt Pedersen as Senior Vice President Human Resources 9/3/2013 9:25:33 AM
1234567